USD10
ELOX Shares
About Eloxx PharmaEloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

USD10
ELOX Shares
About Eloxx PharmaEloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Stats

TRADING WINDOW

Closed

OPENS AT

Jul 31 at 1:30 PM GMT+0

MARKET CAP

$59.89M

OPEN PRICE

$13.90

LOW (1Y)

$0.000001

HIGH (1Y)

$17.50

LOW (24H)

$13.79

HIGH (24H)

$18.42

VOLUME (24H)

$53.27K

182.2%

Price history

Time
Price
Change
Today
$13.90
25.40%
1 Day
$13.90
25.40%
1 Week
$11.81
47.54%
1 Month
$12.34
41.25%
1 Year
Not enough data
Not enough data
Past performance is not a reliable indicator of future results.

Discover more

Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.